New biological sequence listings requirements for patent applications

From 1 July 2022 a new global standard will apply to all new patent applications containing biological sequence listings.

The new standard, WIPO ST.26, applies to biological sequences with ten or more defined nucleotides or with four or more defined amino acids. This change is being adopted by all WIPO contracting states including the UK IPO.

New software, WIPO Sequence, is available for applicants to compile sequence listings.

If you file patent applications that disclose biological sequences, please make sure you are ready for the ‘Big Bang’ release on 1 July. Details of the IPO’s new requirements and procedures are available here.

Date published: 24 May 2022

More Articles

> Member News, News

Practical considerations around MyEPO/fee changes from 1 April 2024

Read more

> News

UK leads the way in IP-secured lending for high-growth SMEs

Read more

Shopping Basket

No products in the cart.

Skip to content